Genetic Technologies (GENE)

Revenue in 2008 (TTM): HK$0.13 B

According to Genetic Technologies's latest financial reports the company's current revenue (TTM

) is HK$0.13 B. In 2007 the company made a revenue of HK$0.12 B an increase over the revenue in the year 2006 that were of HK$54.46 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Genetic Technologies from 2005 to 2008

Annual revenue

Year	Revenue	Change
2008 (TTM)	HK$0.13 B	2.82%
2007	HK$0.12 B	138.31%
2006	HK$54.46 M	0.65%
2005	HK$54.11 M

Revenue for similar companies or competitors

Company	Revenue	Revenue differencediff.	Country
Eterna Therapeutics ERNA	HK$1.26 M	-99.06%	🇺🇸 USA
Myriad Genetics MYGN	HK$6.25 B	4,579.43%	🇺🇸 USA
LabCorp LH	HK$97.34 B	72,743.30%	🇺🇸 USA
Quest Diagnostics DGX	HK$72.85 B	54,417.56%	🇺🇸 USA
Compugen CGEN	HK$0.33 B	149.20%	🇮🇱 Israel
Danaher DHR	HK$164.51 B	123,010.75%	🇺🇸 USA
Thermo Fisher Scientific TMO	HK$330.08 B	246,914.82%	🇺🇸 USA
Neogen NEOG	HK$7.20 B	5,291.22%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Revenue for Genetic Technologies (GENE)

Revenue in 2008 (TTM): HK$0.13 B